அடிப்படையிலானது மருந்து கண்டுபிடிப்பு News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from அடிப்படையிலானது மருந்து கண்டுபிடிப்பு. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In அடிப்படையிலானது மருந்து கண்டுபிடிப்பு Today - Breaking & Trending Today

Global $24.1 Billion Bioinformatics Markets & Technologies to 2025


Share:
ResearchAndMarkets.com s offering.
The global market for bioinformatics should grow from $16.1 billion in 2020 to $24.1 billion by 2025 with a compound annual growth rate (CAGR) of 8.4% for the period of 2020-2025.
The high growth rate of this segment is attributed to factors such as the demand for antibodies research, the expanding COVID-19 pandemic, epidemics of other infectious diseases, and an increase in R&D activities by key companies to develop new data regarding genetic consequences to counter the rise in different infectious diseases globally.
Moreover, the advancement of biological discoveries will result in the need for more molecular targets to be detected by their antibodies and the usage of different bioinformatic tools. For example, publicly available datasets of human BCR were selected to represent different sequencing platforms such as Illumina MiSeq, Roche 454, and Ion Torrent. ....

United States , South Africa , Geneva Bioformatics Genebio , Dassault Systemes Biovia , Laura Wood , Ligand Software Entwicklungs Und Consulting Gmbh , Health Technologies , Gns Healthcare Inc , Clinical Research , Macvector Inc , Bioinformatics Analytical Software , Compugen Ltd , Office Hours Call , Global Company Market Ranking Analysis , Drug Development , Technology Platforms , Proteomic Research , Ocimum Biosolutions Ltd , Biomatters Ltd , Thermo Fisher Scientific Inc , Dnastar Inc , Real Time Genomics Inc , Research Funding For Bioinformatics , Agilent Technologies Inc , Molecular Networks Gmbh , Electronic Health Records ,

IPS cells in drug screenings for COVID-19


Kyoto University
The Haruhisa Inoue lab uses iPS cells to find potential drugs against RNA viruses.
The last year has seen intensive research around the world on SARS-CoV-2, the virus responsible for the COVID-19 pandemic. Despite several vaccines already available, the rapid mutation of the virus is causing concern that the infection will continue to spread. A new study led by CiRA Professor Haruhisa Inoue shows that iPS cells can assist in finding effective drugs for RNA viruses.
HIV, Ebola virus, and now the SARS-CoV-2 pandemic, in the last half century, RNA viruses have been responsible for many of society’s greatest health calamities. One of the great challenges in managing these viruses is their rapid mutation rate. Indeed, it is possible that as SARS-Cov-2 continues to mutate, it may need, like influenza, new vaccines annually. ....

Sayaka Okada , Greifswald Insel Riems , Haruhisa Inoue , Keiko Imamura , Jitsutaro Kawaguchi , Kyohei Nishi , Thomas Hoenen , Akira Ohta , Yasuteru Sakurai , Jiro Yasuda , Tsugumine Shu , Ps Cells Team , Bioresource Research Center , Institute Of Molecular Virology , Nagasaki University , National Research Center , Ps Cell Research , Rd Center , Kyoto University , Institute Of Tropical Medicine , Id Pharma Co Ltd , Department Of Emerging Infectious Diseases , Development Team , Based Drug Discovery , Resource Research Center , Advanced Intelligence Project ,